Bora Pharmaceuticals, a contract development and manufacturing organization, is integrating AI into its operations to enhance efficiency from product development to commercial manufacturing. Helen Clark, the global lead of manufacturing science and technology, highlighted the challenges faced by manufacturers, including data quality and regulatory hurdles, which necessitate modernization of operations.
The importance of AI in manufacturing is underscored by the fact that many manufacturers struggle with unconnected data across various systems. Clark emphasized that modern manufacturing equipment must be supported by effective processes and collaboration among teams to yield better outcomes and improve reliability in manufacturing processes.
Looking ahead, Bora Pharmaceuticals aims to continue refining its AI applications and operational strategies to address ongoing challenges in the industry. No further timeline was disclosed at the time of publication.
Editor's Note
The integration of AI in pharmaceutical manufacturing is crucial for enhancing operational efficiency and addressing data management challenges. As companies like Bora Pharmaceuticals modernize their processes, they set a precedent for the industry, highlighting the need for collaboration and innovation in manufacturing practices. This trend may influence procurement strategies and investment decisions in the sector.
Copyright Notice
This briefing is an independently written summary based on publicly available reporting and is provided for industry information and news discovery. The original report and source publication are credited and linked where applicable. RobotToday does not claim ownership of third-party source material.
Rights concerns? If you believe any material in this briefing infringes your copyright or other rights, please contact [email protected] with the relevant URL and details. We will review the matter and take appropriate action where warranted.
Leave a comment